Product Data Sheet

RDEA-427

Catalog No. A51747

main product photo
RDEA-427 is a pyrrolopyrimidine derivative that acts as a non-nucleoside reverse transcriptase inhibitor (NNRTI) targeting HIV-1. This compound demonstrates efficacy against both wild-type and NNRTI-resistant mutant strains of HIV-1. RDEA-427 is suitable for research applications focused on HIV infection and the mechanisms of viral resistance.
Chemical Information
Catalog NumA51747
M. Wt380.41
FormulaC22H16N6O
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.914496-19-8
Synonyms
SMILESN#CC1=CC=C(C=C1)NC=2N=C(OC=3C(=CC(C#N)=CC3C)C)C=4C=CNC4N2
Biological Activity
DescriptionRDEA-427 is a pyrrolopyrimidine derivative that acts as a non-nucleoside reverse transcriptase inhibitor (NNRTI) targeting HIV-1. This compound demonstrates efficacy against both wild-type and NNRTI-resistant mutant strains of HIV-1. RDEA-427 is suitable for research applications focused on HIV infection and the mechanisms of viral resistance.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.